Accounting Policies [Abstract] | Period [Axis] |
---|
2015-11-01 - 2016-10-29 |
---|
Accounting Policies [Abstract] | |
Reclassified Unamortized Debt Issuance Costs Reported in Balance Sheet [Table Text Block] | | | | | | | | | | | | | | | October 31, 2015 as presented | | Reclassifications | | October 31, 2015 as adjusted | Other assets | $ | 43,962 |
| | $ | (3,401 | ) | | $ | 40,561 |
| Total other assets | $ | 2,338,520 |
| | $ | (3,401 | ) | | $ | 2,335,119 |
| Total assets | $ | 7,062,178 |
| | $ | (3,401 | ) | | $ | 7,058,777 |
| Current debt | $ | 374,839 |
| | $ | (245 | ) | | $ | 374,594 |
| Current liabilities | $ | 1,113,830 |
| | $ | (245 | ) | | $ | 1,113,585 |
| Long-term debt | $ | 498,497 |
| | $ | (3,156 | ) | | $ | 495,341 |
| Total non-current liabilities | $ | 875,389 |
| | $ | (3,156 | ) | | $ | 872,233 |
| Total liabilities and shareholders equity | $ | 7,062,178 |
| | $ | (3,401 | ) | | $ | 7,058,777 |
|
|
OffsettingAssetsLiabilitiesTableTextBlockTableTextBlock [Table Text Block] | | | | | | | | | | | October 29, 2016 | | October 31, 2015 | Gross amount of recognized liabilities | $ | (5,788 | ) | | $ | (3,896 | ) | Gross amounts of recognized assets offset in the consolidated balance sheet | 557 |
| | 813 |
| Net liabilities presented in the consolidated balance sheet | $ | (5,231 | ) | | $ | (3,083 | ) |
Interest Rate Exposure Management — The Company's current and future debt may be subject to interest rate risk. The Company utilizes interest rate derivatives to alter interest rate exposure in an attempt to reduce the effects of these changes. On October 28, 2014, the Company entered into forward starting interest rate swap transactions to hedge its exposure to the variability in future cash flows due to changes in interest rates for the first $500 million of debt issuances that were expected to occur in the future. On December 1, 2015, these forward starting swaps were terminated resulting in a loss of $33.4 million. On December 14, 2015, the Company issued the 2025 Notes and 2045 Notes. The loss was recorded in OCI and will be reclassified out of OCI to interest expense on a straight line basis over the 10-year term of the 2025 Notes. The market risk associated with the Company’s derivative instruments results from currency exchange rate or interest rate movements that are expected to offset the market risk of the underlying transactions, assets and liabilities being hedged. The counterparties to the agreements relating to the Company’s derivative instruments consist of a number of major international financial institutions with high credit ratings. Based on the credit ratings of the Company’s counterparties as of October 29, 2016, nonperformance is not perceived to be a material risk. Furthermore, none of the Company’s derivatives are subject to collateral or other security arrangements and none contain provisions that are dependent on the Company’s credit ratings from any credit rating agency. While the contract or notional amounts of derivative financial instruments provide one measure of the volume of these transactions, they do not represent the amount of the Company’s exposure to credit risk. The amounts potentially subject to credit risk (arising from the possible inability of counterparties to meet the terms of their contracts) are generally limited to the amounts, if any, by which the counterparties’ obligations under the contracts exceed the obligations of the Company to the counterparties. As a result of the above considerations, the Company does not consider the risk of counterparty default to be significant. The Company records the fair value of its derivative financial instruments in its consolidated financial statements in other current assets, other assets or accrued liabilities, depending on their net position, regardless of the purpose or intent for holding the derivative contract. Changes in the fair value of the derivative financial instruments are either recognized periodically in earnings or in shareholders’ equity as a component of OCI. Changes in the fair value of cash flow hedges are recorded in OCI and reclassified into earnings when the underlying contract matures. Changes in the fair values of derivatives not qualifying for hedge accounting or the ineffective portion of designated hedges are reported in earnings as they occur. For information on the unrealized holding gains (losses) on derivatives included in and reclassified out of accumulated other comprehensive income into the consolidated statement of income related to forward foreign currency exchange contracts, see Note 2o, Accumulated Other Comprehensive (Loss) Income of these Notes to Consolidated Financial Statements.
|
Unrealized gains and losses on available-for-sale securities classified as short-term investments | unrealized gains and losses on available-for-sale securities classified as short-term investments at October 29, 2016 and October 31, 2015 were as follows: | | | | | | | | | | 2016 | | 2015 | Unrealized gains on securities classified as short-term investments | $ | 846 |
| | $ | 233 |
| Unrealized losses on securities classified as short-term investments | (294 | ) | | (584 | ) | Net unrealized gain (loss) on securities classified as short-term investments | $ | 552 |
| | $ | (351 | ) |
|
Cash and cash equivalents and short term investments | The components of the Company’s cash and cash equivalents and short-term investments as of October 29, 2016 and October 31, 2015 were as follows: | | | | | | | | | | 2016 | | 2015 | Cash and cash equivalents: | |
| | |
| Cash | $ | 67,877 |
| | $ | 72,638 |
| Available-for-sale | 693,255 |
| | 807,935 |
| Held-to-maturity | 160,000 |
| | 3,780 |
| Total cash and cash equivalents | $ | 921,132 |
| | $ | 884,353 |
| Short-term investments: | |
| | |
| Available-for-sale | $ | 3,110,011 |
| | $ | 2,144,575 |
| Held-to-maturity (less than one year to maturity) | 24,650 |
| | — |
| Total short-term investments | $ | 3,134,661 |
| | $ | 2,144,575 |
|
|
Supplemental cash flow statement Information | | | | | | | | | | | | | | | 2016 | | 2015 | | 2014 | Cash paid during the fiscal year for: | |
| | |
| | |
| Income taxes | $ | 77,918 |
| | $ | 142,931 |
| | $ | 73,067 |
| Interest | $ | 41,701 |
| | $ | 25,625 |
| | $ | 27,931 |
|
|
Inventories | Inventories at October 29, 2016 and October 31, 2015 were as follows: | | | | | | | | | | 2016 | | 2015 | Raw materials | $ | 20,263 |
| | $ | 21,825 |
| Work in process | 232,196 |
| | 261,520 |
| Finished goods | 124,096 |
| | 128,969 |
| Total inventories | $ | 376,555 |
| | $ | 412,314 |
|
|
Useful lives of property, plant and equipment | Depreciation is based on the following ranges of estimated useful lives: | | | Buildings | Up to 25 years | Machinery & equipment | 3-8 years | Office equipment | 3-8 years |
|
Changes in goodwill | The following table presents the changes in goodwill during fiscal 2016 and fiscal 2015: | | | | | | | | | | 2016 | | 2015 | Balance at beginning of year | $ | 1,636,526 |
| | $ | 1,642,438 |
| Acquisition of Hittite (Note 6) (1) | — |
| | (1,105 | ) | Goodwill adjustment related to other acquisitions (2) | 44,046 |
| | 3,663 |
| Foreign currency translation adjustment | (1,456 | ) | | (8,470 | ) | Balance at end of year | $ | 1,679,116 |
| | $ | 1,636,526 |
|
|
Intangible assets consisted of the following: | As of October 29, 2016 and October 31, 2015, the Company’s intangible assets consisted of the following: | | | | | | | | | | | | | | | | | | October 29, 2016 | | October 31, 2015 | | Gross Carrying Amount | | Accumulated Amortization | | Gross Carrying Amount | | Accumulated Amortization | Customer relationships | $ | 649,159 |
| | $ | 158,979 |
| | $ | 624,900 |
| | $ | 88,913 |
| Technology-based | 22,231 |
| | 8,911 |
| | 15,100 |
| | 4,834 |
| Trade-name | 600 |
| | 60 |
| | — |
| | — |
| Backlog | 200 |
| | — |
| | — |
| | — |
| IPR&D (1) | 46,175 |
| | 1,047 |
| | 37,264 |
| | — |
| Total (2) (3) | $ | 718,365 |
| | $ | 168,997 |
| | $ | 677,264 |
| | $ | 93,747 |
|
|
Schedule of expected annual amortization expense | The Company expects annual amortization expense for intangible assets as follows: | | | | | Fiscal Year | Amortization Expense | 2017 | $ | 79,794 |
| 2018 | $ | 78,475 |
| 2019 | $ | 75,286 |
| 2020 | $ | 75,047 |
| 2021 | $ | 74,627 |
|
|
Fair value of hedging instruments | The fair values of forward foreign currency derivative instruments designated as hedging instruments in the Company’s consolidated balance sheets as of October 29, 2016 and October 31, 2015 were as follows: | | | | | | | | | | | | | | Fair Value At | | Balance Sheet Location | | October 29, 2016 | | October 31, 2015 | Forward foreign currency exchange contracts | Accrued liabilities | | $ | 5,260 |
| | $ | 3,091 |
|
|
Fair value of financial assets and liabilities | The tables below, set forth by level, presents the Company’s financial assets and liabilities, excluding accrued interest components, that were accounted for at fair value on a recurring basis as of October 29, 2016 and October 31, 2015. The tables exclude cash on hand and assets and liabilities that are measured at historical cost or any basis other than fair value. As of October 29, 2016 and October 31, 2015, the Company held $252.5 million and $76.4 million, respectively, of cash and held-to-maturity investments that were excluded from the tables below. | | | | | | | | | | | | | | | | | | October 29, 2016 | | Fair Value measurement at Reporting Date using: | | | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | Significant Other Observable Inputs (Level 2) | | Significant Other Unobservable Inputs (Level 3) | | Total | Assets | | | | | | | | Cash equivalents: | | | | | | | | Available-for-sale: | | | | | | | | Institutional money market funds | $ | 277,595 |
| | $ | — |
| | $ | — |
| | $ | 277,595 |
| Corporate obligations (1) | — |
| | 415,660 |
| | — |
| | 415,660 |
| Short - term investments: | | | | | | | | Available-for-sale: | | | | | | | | Securities with one year or less to maturity: | | | | | | | | Corporate obligations (1) | — |
| | 2,518,148 |
| | — |
| | 2,518,148 |
| Floating rate notes, issued at par | — |
| | 29,989 |
| | — |
| | 29,989 |
| Floating rate notes (1) | — |
| | 561,874 |
| | — |
| | 561,874 |
| Other assets: | | | | | | | | Deferred compensation investments | 26,916 |
| | — |
| | — |
| | 26,916 |
| Total assets measured at fair value | $ | 304,511 |
| | $ | 3,525,671 |
| | $ | — |
| | $ | 3,830,182 |
| Liabilities | | | | | | | | Contingent consideration | — |
| | — |
| | 7,555 |
| | 7,555 |
| Forward foreign currency exchange contracts (2) | — |
| | 5,231 |
| | — |
| | 5,231 |
| Total liabilities measured at fair value | $ | — |
| | $ | 5,231 |
| | $ | 7,555 |
| | $ | 12,786 |
|
| | (1) | The amortized cost of the Company’s investments classified as available-for-sale as of October 29, 2016 was $3.5 billion. |
| | (2) | The Company has netting arrangements by counterparty with respect to derivative contracts. See Note 2i, Derivative Instruments and Hedging Agreements, of these Notes to Consolidated Financial Statements for more information related to the Company's master netting arrangements. |
| | | | | | | | | | | | | | | | | | October 31, 2015 | | Fair Value measurement at Reporting Date using: | | | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | Significant Other Observable Inputs (Level 2) | | Significant Other Unobservable Inputs (Level 3) | | Total | Assets | | | | | | | | Cash equivalents: | | | | | | | | Available-for-sale: | | | | | | | | Institutional money market funds | $ | 198,853 |
| | $ | — |
| | $ | — |
| | $ | 198,853 |
| Corporate obligations (1) | — |
| | 609,082 |
| | — |
| | 609,082 |
| Short - term investments: | | | | | | | | Available-for-sale: | | | | | | | | Securities with one year or less to maturity: | | | | | | | | Corporate obligations (1) | — |
| | 1,899,374 |
| | — |
| | 1,899,374 |
| Floating rate notes, issued at par | — |
| | 99,648 |
| | — |
| | 99,648 |
| Floating rate notes (1) | — |
| | 145,553 |
| | — |
| | 145,553 |
| Other assets: | | | | | | | | Deferred compensation investments | 24,124 |
| | — |
| | — |
| | 24,124 |
| Total assets measured at fair value | $ | 222,977 |
| | $ | 2,753,657 |
| | $ | — |
| | $ | 2,976,634 |
| Liabilities | | | | | | | | Contingent consideration | — |
| | — |
| | 2,843 |
| | 2,843 |
| Forward foreign currency exchange contracts (2) | — |
| | 3,083 |
| | — |
| | 3,083 |
| Interest rate swap agreements | — |
| | 32,737 |
| | — |
| | 32,737 |
| Total liabilities measured at fair value | $ | — |
| | $ | 35,820 |
| | $ | 2,843 |
| | $ | 38,663 |
|
| | (1) | The amortized cost of the Company’s investments classified as available-for-sale as of October 31, 2015 was $2.6 billion. |
| | (2) | The Company has master netting arrangements by counterparty with respect to derivative contracts. See Note 2i, Derivative Instruments and Hedging Agreements, of these Notes to Consolidated Financial Statements for more information related to the Company's master netting arrangements. |
|
Schedule of fair value inputs | The fair value measurement of the contingent consideration encompasses the following significant unobservable inputs: | | | Unobservable Inputs | Range | Potential contingent consideration payments | $8,500 | Discount rate | 0% - 2% | Timing of cash flows | 1 to 3 years | Probability of achievement | 90% - 100% |
|
Change in the fair value of the contingent consideration | The following table summarizes the change in the fair value of the contingent consideration measured using significant unobservable inputs (Level 3) from November 1, 2014 to October 29, 2016: | | | | | | Contingent Consideration | Balance as of November 1, 2014 | $ | 4,806 |
| Payment made (1) | (2,000 | ) | Fair value adjustment (2) | (137 | ) | Effect of foreign currency | 174 |
| Balance as of October 31, 2015 | $ | 2,843 |
| Contingent consideration liability recorded | 7,500 |
| Payment made (1) | (1,489 | ) | Fair value adjustment (2) | (888 | ) | Effect of foreign currency | (411 | ) | Balance as of October 29, 2016 | $ | 7,555 |
|
| | (1) | The payment is reflected in the statements of cash flows as cash used in financing activities related to the liability recognized at fair value as of the acquisition date and as cash provided by operating activities related to the fair value adjustments previously recognized in earnings. |
| | (2) | Recorded in research and development expense in the consolidated statements of income. |
|
Components of accumulated other comprehensive (loss) | The components of accumulated other comprehensive loss at October 29, 2016 and October 31, 2015 consisted of the following, net of tax:
| | | | | | | | | | | | | | | | | | | | | | | | | | Foreign currency translation adjustment | | Unrealized holding gains on available for sale securities classified as short-term investments | | Unrealized holding (losses) on available for sale securities classified as short-term investments | | Unrealized holding Gains on Derivatives | | Pension Plans | | Total | October 31, 2015 | $ | (18,057 | ) | | $ | 216 |
| | $ | (544 | ) | | $ | (17,692 | ) | | $ | (14,774 | ) | | $ | (50,851 | ) | Other comprehensive income before reclassifications | (4,831 | ) | | 613 |
| | 290 |
| | (5,532 | ) | | (14,212 | ) | | (23,672 | ) | Amounts reclassified out of other comprehensive income | — |
| | — |
| | — |
| | 4,487 |
| | 847 |
| | 5,334 |
| Tax effects | (1,175 | ) | | (29 | ) | | (27 | ) | | (147 | ) | | (3,247 | ) | | (4,625 | ) | Other comprehensive income | (6,006 | ) | | 584 |
| | 263 |
| | (1,192 | ) | | (16,612 | ) | | (22,963 | ) | October 29, 2016 | $ | (24,063 | ) | | $ | 800 |
| | $ | (281 | ) | | $ | (18,884 | ) | | $ | (31,386 | ) | | $ | (73,814 | ) |
|
Computation of basic and diluted earnings per share | The following table sets forth the computation of basic and diluted earnings per share: | | | | | | | | | | | | | | 2016 | | 2015 | | 2014 | Net Income | $ | 861,664 |
| | $ | 696,878 |
| | $ | 629,320 |
| Basic shares: | |
| | |
| | |
| Weighted average shares outstanding | 308,736 |
| | 312,660 |
| | 313,195 |
| Earnings per share basic | $ | 2.79 |
| | $ | 2.23 |
| | $ | 2.01 |
| | | | | | | Diluted shares: | |
| | |
| | |
| Weighted average shares outstanding | 308,736 |
| | 312,660 |
| | 313,195 |
| Assumed exercise of common stock equivalents | 3,572 |
| | 4,212 |
| | 4,832 |
| Weighted average common and common equivalent shares | 312,308 |
| | 316,872 |
| | 318,027 |
| Earnings per share diluted | $ | 2.76 |
| | $ | 2.20 |
| | $ | 1.98 |
| Anti-dilutive shares related to: | |
| | |
| | |
| Outstanding stock options | 3,077 |
| | 2,089 |
| | 2,911 |
|
|
Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] |
| | | | | | | | | | | | | | 2016 | | 2015 | | | Comprehensive Income Component | | | | | | Location | Unrealized holding (losses) gains on derivatives | | | | | | | Currency forwards | | $ | 2,059 |
| | $ | 9,235 |
| | Cost of sales | | | 1,038 |
| | 5,200 |
| | Research and development | | | (579 | ) | | 8,361 |
| | Selling, marketing, general and administrative | | | — |
| | (1,466 | ) | | (a) | | | — |
| | (8,723 | ) | | Other operating expense (b) | Treasury rate lock | | (1,096 | ) | | (1,096 | ) | | Interest expense | Swap rate lock | | 3,065 |
| | — |
| | Interest expense | | | 4,487 |
| | 11,511 |
| | Total before tax | | | (1,050 | ) | | (1,064 | ) | | Tax | | | $ | 3,437 |
| | $ | 10,447 |
| | Net of tax | | | | | | | | Amortization of pension components | | | | | | | Transition obligation | | $ | 17 |
| | $ | 18 |
| | (c) | Prior service credit and curtailment recognition | | — |
| | (229 | ) | | (c) | Actuarial losses and settlement recognition | | 830 |
| | 7,378 |
| | (c) | | | 847 |
| | 7,167 |
| | | Irish pension curtailment/settlement | | — |
| | 231,151 |
| | Other operating expense (c) | | | 847 |
| | 238,318 |
| | Total before tax | | | (228 | ) | | (28,875 | ) | | Tax | | | $ | 619 |
| | $ | 209,443 |
| | Net of tax | | | | | | | | Total amounts reclassified out of accumulated other comprehensive income, net of tax | | $ | 4,056 |
| | $ | 219,890 |
| | |
|